About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 548498, 12 pages
http://dx.doi.org/10.1155/2013/548498
Research Article

A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Wu Tou Tang Acting on Rheumatoid Arthritis by Integrating Network Analysis

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16, Nanxiaojie, Dongzhimennei, Beijing 100700, China

Received 11 January 2013; Accepted 20 February 2013

Academic Editor: Aiping Lu

Copyright © 2013 Yanqiong Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Böhler, H. Radner, M. Ernst et al., “Rheumatoid arthritis and falls: the influence of disease activity,” Rheumatology, vol. 51, no. 11, pp. 2051–2057, 2012. View at Publisher · View at Google Scholar
  2. J. Liu and R. L. Liu, “The potential role of Chinese medicine in ameliorating extra-articular manifestations of rheumatoid arthritis,” Chinese Journal of Integrative Medicine, vol. 17, no. 10, pp. 735–737, 2011. View at Publisher · View at Google Scholar
  3. S. Y. Zhang and J. Liu, “Clinical observalion of modified Wu Tou Tang in the treatment of active rheumatoid arthriti,” Chinese Journal of Traditional Medical Science and Technology, vol. 17, pp. 326–327, 2010.
  4. W. D. Hu, C. S. Lin, D. Q. Kong et al., “Clinical observalion of modified Guizhishaoyaozbimu decoction in the treatment of active rheumatoid arthriti,” Chinese Journal of Primary Medicine and Pharmacy, vol. 12, pp. 1699–1700, 2005.
  5. N. Lin, C. Liu, C. Xiao et al., “Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice,” Biochemical Pharmacology, vol. 73, no. 1, pp. 136–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. P. Zhu and H. J. Woerdenbag, “Traditional Chinese herbal medicine,” Pharmacy World and Science, vol. 17, no. 4, pp. 103–112, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Zheng, T. Yan, W. Chen, L. Ye, L. Tang, and Z. Liu, “Pharmacokinetic determination of ephedrine in Herba Ephedrae and Wu Tou Tang decoctions in rats using ultra performance liquid chromatography tandem mass spectrometry,” Xenobiotica, vol. 42, no. 8, pp. 775–783, 2012. View at Publisher · View at Google Scholar
  8. C. Elder, C. Ritenbaugh, M. Aickin et al., “Reductions in pain medication use associated with traditional chinese medicine for chronic pain,” The Permanente Journal, vol. 16, no. 3, pp. 18–23, 2012.
  9. H. J. Wang and B. H. Chiang, “Anti-diabetic effect of a traditional Chinese medicine formula,” Food & Function, vol. 3, no. 11, pp. 1161–1169, 2012. View at Publisher · View at Google Scholar
  10. H. Shi, C. Zhou, Y. Li, G. Wang, and Y. Sun, “Anti-inflammatory effect of aconitines,” Zhongguo Zhong Yao Za Zhi, vol. 15, no. 3, pp. 174–192, 1990. View at Scopus
  11. J. Hallas, L. Bjerrum, H. Støvring, and M. Andersen, “Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study,” American Journal of Epidemiology, vol. 168, no. 8, pp. 966–973, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Tao, X. Xu, X. Wang et al., “Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease,” Journal of Ethnopharmacology, vol. 145, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  13. Z. H. Liu and X. B. Sun, “Network pharmacology: new opportunity for the modernization of traditional Chinese medicine,” Yao Xue Xue Bao, vol. 47, pp. 696–703, 2012.
  14. S. Zhao and S. Li, “Network-based relating pharmacological and genomic spaces for drug target identification,” PLoS ONE, vol. 5, no. 7, Article ID e11764, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Li, B. Zhang, and N. Zhang, “Network target for screening synergistic drug combinations with application to traditional Chinese medicine,” BMC Systems Biology, vol. 5, supplement 1, p. S10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Li, B. Zhang, D. Jiang, Y. Wei, and N. Zhang, “Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae,” BMC Bioinformatics, vol. 11, supplement 11, p. S6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Y.-C. Chen, “TCM database Taiwan: the world's largest traditional Chinese medicine database for drug screening In Silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. S. Wishart, C. Knox, A. C. Guo et al., “DrugBank: a knowledgebase for drugs, drug actions and drug targets,” Nucleic Acids Research, vol. 36, no. 1, pp. D901–D906, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Y. Chen, S. R. Mamidipalli, and T. Huan, “HAPPI: an online database of comprehensive human annotated and predicted protein interactions,” BMC Genomics, vol. 10, supplement 1, p. S16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Matthews, G. Gopinath, M. Gillespie et al., “Reactome knowledgebase of human biological pathways and processes,” Nucleic Acids Research, vol. 37, no. 1, pp. D619–D622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. R. Brown and I. Jurisica, “Online predicted human interaction database,” Bioinformatics, vol. 21, no. 9, pp. 2076–2082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Aranda, P. Achuthan, Y. Alam-Faruque et al., “The IntAct molecular interaction database in 2010,” Nucleic Acids Research, vol. 38, no. 1, Article ID gkp878, pp. D525–D531, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. S. Keshava Prasad, R. Goel, K. Kandasamy et al., “Human protein reference database-2009 update,” Nucleic Acids Research, vol. 37, no. 1, pp. D767–D772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Ceol, A. Chatr Aryamontri, L. Licata et al., “MINT, the molecular interaction database: 2009 update,” Nucleic Acids Research, vol. 38, no. 1, Article ID gkp983, pp. D532–D539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Lehne and T. Schlitt, “Protein-protein interaction databases: keeping up with growing interactomes,” Human Genomics, vol. 3, no. 3, pp. 291–297, 2009. View at Scopus
  26. T. Beuming, L. Skrabanek, M. Y. Niv, P. Mukherjee, and H. Weinstein, “PDZBase: a protein-protein interaction database for PDZ-domains,” Bioinformatics, vol. 21, no. 6, pp. 827–828, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Zhu, Z. Shi, C. Qin et al., “Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery,” Nucleic Acids Research, vol. 40, no. 1, pp. D1128–D1136, 2012. View at Publisher · View at Google Scholar
  28. S. Briesemeister, J. Rahnenführer, and O. Kohlbacher, “Going from where to why—interpretable prediction of protein subcellular localization,” Bioinformatics, vol. 26, no. 9, Article ID btq115, pp. 1232–1238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Dennis Jr., B. T. Sherman, D. A. Hosack et al., “DAVID: database for annotation, visualization, and integrated discovery,” Genome Biology, vol. 4, no. 5, p. P3, 2003. View at Scopus
  30. J. Wixon and D. Kell, “The Kyoto encyclopedia of genes and genomes—KEGG,” Yeast, vol. 17, no. 1, pp. 48–55, 2000. View at Scopus
  31. Y. Wang, Z. Liu, C. Li et al., “Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 698531, 10 pages, 2012. View at Publisher · View at Google Scholar
  32. S. Wuchty and E. Almaas, “Evolutionary cores of domain co-occurrence networks,” BMC Evolutionary Biology, vol. 5, p. 24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Zsoldos, D. Reid, A. Simon, B. S. Sadjad, and A. P. Johnson, “eHiTS: an innovative approach to the docking and scoring function problems,” Current Protein and Peptide Science, vol. 7, no. 5, pp. 421–435, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. P. W. Rose, B. Beran, C. Bi et al., “The RCSB protein data bank: redesigned web site and web services,” Nucleic Acids Research, vol. 39, no. 1, pp. D392–D401, 2011. View at Publisher · View at Google Scholar
  35. S. B. Su, A. Lu, S. Li, and W. Jia, “Evidence-based ZHENG: a traditional Chinese medicine syndrome,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 246538, 2 pages, 2012. View at Publisher · View at Google Scholar
  36. S. Li, Z. Q. Zhang, L. J. Wu, X. G. Zhang, Y. D. Li, and Y. Y. Wang, “Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network,” IET Systems Biology, vol. 1, no. 1, pp. 51–60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. E. V. Davies and M. B. Hallett, “Cytosolic Ca2+ signalling in inflammatory neutrophils: implications for rheumatoid arthritis (Review),” International Journal of Molecular Medicine, vol. 1, no. 2, pp. 485–490, 1998. View at Scopus
  38. C. Lu, C. Xiao, G. Chen et al., “Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell,” Rheumatology International, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. H. Yeh, H. Y. Yeh, and V. W. Soo, “A network flow approach to predict drug targets from microarray data, disease genes and interactome network-case study on prostate cancer,” Journal of Clinical Bioinformatics, vol. 2, no. 1, p. 1, 2012. View at Publisher · View at Google Scholar
  40. P. Holme, B. J. Kim, C. N. Yoon, and S. K. Han, “Attack vulnerability of complex networks,” Physical Review E, vol. 65, no. 5, Article ID 056109, pp. 056109/1–056109/14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. A. M. Malfait, A. S. Malik, L. Marinova-Mutafchieva, D. M. Butler, R. N. Maini, and M. Feldmann, “The β2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action,” Journal of Immunology, vol. 162, no. 10, pp. 6278–6283, 1999. View at Scopus
  42. M. Wahle, G. Hanefeld, S. Brunn et al., “Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis,” Arthritis Research and Therapy, vol. 8, no. 5, p. R138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. C. G. O. Baerwald, M. Wahle, T. Ulrichs et al., “Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis,” Immunobiology, vol. 200, no. 1, pp. 77–91, 1999. View at Scopus
  44. G. Pont-Kingdon, J. Bohnsack, K. Sumner et al., “Lack of association between beta 2-adrenergic receptor polymorphisms and juvenile idiopathic arthritis,” Scandinavian Journal of Rheumatology, vol. 38, no. 2, pp. 91–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Xu, L. Ärlehag, S. B. Rantapää-Dahlquist, and A. K. Lefvert, “β2-adrenergic receptor gene single-nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden,” Scandinavian Journal of Rheumatology, vol. 33, no. 6, pp. 395–398, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Malysheva, M. Pierer, U. Wagner, M. Wahle, U. Wagner, and C. G. Baerwald, “Association between β2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope,” Annals of the Rheumatic Diseases, vol. 67, no. 12, pp. 1759–1764, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Lorton, C. Lubahn, and D. L. Bellinger, “Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases,” Current Drug Targets-Inflammation & Allergy, vol. 2, no. 1, pp. 1–30, 2003.
  48. C. Roupe Van Der Voort, C. J. Heijnen, N. Wulffraat, W. Kuis, and A. Kavelaars, “Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for α1-adrenergic receptors,” Journal of Neuroimmunology, vol. 110, no. 1-2, pp. 223–229, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Beck, N. Dejeans, C. Glorieux et al., “Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif,” PLoS One, vol. 7, no. 7, Article ID e40795, p. 1, 2012. View at Publisher · View at Google Scholar
  50. S. Solier, K. W. Kohn, B. Scroggins et al., “Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 32, pp. 12866–12872, 2012. View at Publisher · View at Google Scholar
  51. L. Sedlackova, A. Sosna, P. Vavrincova et al., “Heat shock protein gene expression profile may differentiate between rheumatoid arthritis, osteoarthritis, and healthy controls,” Scandinavian Journal of Rheumatology, vol. 40, no. 5, pp. 354–357, 2011. View at Publisher · View at Google Scholar
  52. V. Nicolaidou, M. M. Wong, A. N. Redpath et al., “Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation,” PLoS One, vol. 7, no. 7, Article ID e39871, 2012. View at Publisher · View at Google Scholar
  53. M. Seddighzadeh, A. Gonzalez, B. Ding et al., “Variants within STAT genes reveal association with anticitrullinated protein antibody-negative rheumatoid arthritis in 2 European populations,” Journal of Rheumatology, vol. 39, no. 8, pp. 1509–1516, 2012. View at Publisher · View at Google Scholar
  54. H. Wang, Y. Fang, Y. Wang et al., “Inhibitory effect of curcumol on Jak2-STAT signal pathway molecules of fibroblast-like synoviocytes in patients with rheumatoid arthritis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 746426, 8 pages, 2012. View at Publisher · View at Google Scholar
  55. H. Yoshida, A. Kimura, T. Fukaya et al., “Low dose CP-690, 550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation,” Biochemical and Biophysical Research Communications, vol. 418, no. 2, pp. 234–240, 2012. View at Publisher · View at Google Scholar
  56. S. R. Witzmann, J. D. Turner, S. B. Mériaux, O. C. Meijer, and C. P. Muller, “Epigenetic regulation of the glucocorticoid receptor promoter 1 7 in adult rats,” Epigenetics, vol. 7, no. 11, pp. 1290–1301, 2012. View at Publisher · View at Google Scholar
  57. A. Rauch, V. Gossye, D. Bracke et al., “An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation,” FASEB Journal, vol. 25, no. 4, pp. 1323–1332, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Oda, Y. Nakamura, M. Yamamoto, and M. Kojiro, “Immunohistochemical distribution of tubulin beta II in human normal and neoplastic tissues,” Kurume Medical Journal, vol. 52, no. 4, pp. 117–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Ramos-Ruiz, J. Avila, J. P. Lopez-Bote, C. Bernabeu, and V. Larraga, “Decreased tubulin synthesis in synoviocytes from adjuvant-induced arthritic rats,” Biochimica et Biophysica Acta, vol. 1138, no. 3, pp. 184–190, 1992. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Kamada, M. S. Kurokawa, T. Kato et al., “Proteomic analysis of bone marrow-adherent cells in rheumatoid arthritis and osteoarthritis,” International Journal of Rheumatic Diseases, vol. 15, no. 2, pp. 169–178, 2012. View at Publisher · View at Google Scholar
  61. R. J. Bienstock, “Computational drug design targeting protein-protein interactions,” Current Pharmaceutical Design, vol. 18, no. 9, pp. 1240–1254, 2012.